Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3-5 chronic kidney disease patients

Journal of Diabetes and its Complications

Volumn 28, Issue 1, 2014, Pages 61-65

  Garland, Jocelyn S ^a   Holden, Rachel M ^a   Ross, Robert ^a   Adams, Michael A ^a   Nolan, Robert L ^a   Hopman, Wilma M ^a   Morton, A Ross ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Chronic Kidney Disease; Coronary artery calcification; Fibroblast Growth Factor 23; Insulin Resistance; Phosphorus

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; INSULIN; PARATHYROID HORMONE; FIBROBLAST GROWTH FACTOR; PHOSPHATE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY CALCIFICATION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODERATE RENAL IMPAIRMENT; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; YOUNG ADULT; BLOOD; CALCINOSIS; CHRONIC KIDNEY FAILURE; COMPLICATION; CORONARY ARTERY DISEASE; DISEASE COURSE; GLOMERULUS FILTRATION RATE; METABOLIC SYNDROME X; METABOLISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CALCINOSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHOSPHATES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84891828671     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.09.004     Document Type: Article

References (39)

1. A.S. Agatston, W.R. Janowitz, and F. Hildner Quantification of coronary artery calcium using ultra fast computed tomography Journal of the American College of Cardiology 15 1990 827 832
2. J.F. Ascaso, S. Pardo, J.T. Real, R.I. Lorente, A. Priego, and R. Carmena Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism Diabetes Care 26 2003 3320 3325
3. J. Bacchetta, L. Dubourg, J. Harambat, B. Ranchin, P. Abou-Jaoude, and S. Arnaud et al. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease Journal of Clinical Endocrinology and Metabolism 95 4 2010 1741 1748
4. M. Balci, A. Kirpantur, M. Gulbay, and O.A. Gurbuz Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients Hemodialysis International 14 2010 425 432
5. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada Canadian Journal of Diabetes 27 Suppl. 2 2003 S7 S9
6. C. Catena, G. Giacchetti, M. Novello, G. Colussi, A. Cavarape, and L.A. Sechi Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension American Journal of Hypertension 16 11 Pt 1 2003 973 978
7. A.O. Chavez, M. Molina-Carrion, M.A. Abdul-Ghani, F. Folli, R.A. Defronzo, and D. Tripathy Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance Diabetes Care 32 8 2009 1542 1546
8. S. Devaraj, C. Duncan-Staley, and I. Jialal Evaluation of a method for fibroblast growth factor-23: A novel biomarker of adverse outcomes in patients with renal disease Metabolic Syndrome and Related Disorders 8 6 2010 477 482
9. J.M. Fernández-Real, J. Puig, M. Serrano, M. Sabater, A. Rubió, and J.M. Moreno-Navarrete et al. Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrations PLoS One 8 3 2013 e58961 Epub Mar 21, 2013
10. J.S. Garland, R.M. Holden, P.A. Groome, M. Lam, R.L. Nolan, and A.R. Morton et al. Prevalence and associations of Coronary Artery Calcification in Patients with Stages 3-5 CKD without Cardiovascular Disease American Journal of Kidney Diseases 52 5 2008 849 858
11. R. Greger, F. Lang, G. Marchand, and F.G. Knox Site of renal phosphate resorption. Micropuncture and microperfusion study Pflugers Archive 369 1997 111
12. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 112 2005 2735 2752
13. O. Gutierrez, T. Isakova, E. Rhee, A. Shah, J. Holmes, and G. Collerone et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease Journal of the American Society of Nephrology 16 2005 2205 2215
14. O.M. Gutierrez, J.L. Januzzi, T. Isakova, K. Laliberte, K. Smith, and G. Collerone et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease Circulation 119 2009 2545 2552
15. M.R. Hammerman, S. Rogers, V.A. Hansen, and J.R. Gavin III Insulin stimulates Pi transport in brush border vesicles from proximal tubular segments American Journal of Physiology 247 5 Pt1 1984 E616 E624
16. B.R. Hemmelgarn, F.A. McAlister, S. Grover, M.G. Myers, D.W. McKay, and P. Bolli et al. Canadian Hypertension Education Program. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - blood pressure measurement, diagnosis and assessment of risk Canadian Journal of Cardiology 22 2006 573 581
17. R.M. Holden, A.R. Morton, J.S. Garland, A. Pavlov, A.G. Day, and S.L. Booth Vitamins K and D status in stages 3-5 chronic kidney disease Clinical Journal of the American Society of Nephrology 5 4 2010 590 597
18. N. Itoh, and D.M. Ornitz Functional evolutionary history of the mouse Fgf gene family Developmental Dynamics 237 1 2008 18 27
19. H. Jüppner, M. Wolf, and I.B. Salusky FGF-23: More than a regulator of renal phosphate handling? Journal of Bone and Mineral Research 25 10 2010 2091 2107
20. K. Katai, K. Miyamoto, and S. Kishida et al. Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3 Biochemical Journal 343 1999 705 712
21. J.D. Kerr, R.M. Holden, A.R. Morton, R.L. Nolan, W.M. Hopman, and C.M. Pruss et al. Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease BMC Nephrology 14 2013 26
22. S. Kobayashi, M. Oka, K. Maesato, R. Ikee, T. Mano, and M. Hidekazu et al. Coronary artery calcification, ADMA, and insulin resistance in CKD patients Clinical Journal of the American Society of Nephrology 3 5 2008 1289 1295
23. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group Annals of Internal Medicine 130 1999 461 470
24. A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y. Zhang, and S. Hendrikson et al. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate Annals of Internal Medicine 145 2006 247 254
25. M.A.I. Mirza, J. Alsio, A. Hammarstedt, R.G. Erben, K. Michaelsson, and A. Tivesten et al. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals Arteriosclerosis, Thrombosis, and Vascular Biology 31 2010 219 227
26. H. Murer, N. Hernando, I. Forster, and J. Biber Proximal tubular phosphate reabsorption: Molecular mechanisms Physiological Reviews 80 4 2000 1373 1409
27. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification American Journal of Kidney Diseases 39 2004 S1 S266
28. D. Prié, and G. Friedlander Genetic disorders of renal phosphate transport New England Journal of Medicine 362 25 2010 2399 2409
29. G. Reaven The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals Endocrinology and Metabolism Clinics of North America 33 2 2004 283 303
30. L.A. Sechi, C.A. Griffin, G. Giacchetti, L. Zingaro, C. Catena, and E. Bartoli et al. Abnormalities of insulin receptors in spontaneously hypertensive rats Hypertension 27 4 1996 955 961
31. T. Shimada, I. Urakawa, Y. Yamazaki, H. Hasegawa, R. Hino, and T. Yoneya et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa Biochemical and Biophysical Research Communications 314 2004 409 414
32. S. Stein, A. Bachmann, U. Lössner, J. Kratzsch, M. Blüher, and M. Stumvoll et al. Serum levels of the adipokine FGF21 depend on renal function Diabetes Care 32 1 2009 126 128
33. P. Wahl, H. Xie, and J. Scialla et al. Chronic Renal Insufficiency Cohort Study Group. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease Diabetes Care 35 5 2012 994 1001
34. L. Wexler, B. Brundage, J. Crouse, R. Detrano, V. Fuster, and J. Maddahi et al. Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association Writing Group Circulation 94 1996 1175 1192
35. M. Wojcik, K. Dolezal-Oltarzewska, D. Janus, D. Drozdz, K. Sztefko, and J.B. Starzyk FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results Clinical Endocrinology 77 4 2012 537 540
36. M. Wojcik, D. Janus, K. Dolezal-Oltarzewska, D. Drozdz, K. Sztefko, and J.B. Starzyk The association of FGF23 levels in obese adolescents with insulin sensitivity Journal of Pediatric Endocrinology & Metabolism 25 7-8 2012 687 690
37. A. Yasin, D. Liu, L. Chau, J. Madrenas, and G. Filler Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: A cross-sectional study BMC Nephrology 14 2013 39
38. X. Zhang, D.C. Yeung, M. Karpisek, D. Stejskal, Z.G. Zhou, and F. Liu et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans Diabetes 57 5 2008 1246 1253
39. N. Zhao, and H.S. Tenenhouse Npt2 gene disruption confers resistance to the inhibitory action of parathyroid hormone on renal sodium-phosphate cotransport Endocrinology 141 6 2000 2159 2165